CGEN Q3 2021 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena

CGENCompugen Ltd.

$215M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M

Gross Profit

$5M88.7% margin

Operating Income

-$6M-105.6% margin

Net Income

-$6M-102.6% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

+Infinity%

Balance Sheet

Total Assets

$121M

Total Liabilities

$22M

Stockholders' Equity

$99M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$0	—
Gross Profit	$5M	$0	—
Operating Income	-$6M	-$8M	+23.0%
Net Income	-$6M	-$8M	+20.7%